Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 5
1947 5
1948 6
1949 3
1950 4
1951 15
1952 25
1953 23
1954 23
1955 19
1956 23
1957 21
1958 20
1959 29
1960 19
1961 19
1962 19
1963 37
1964 77
1965 40
1966 30
1967 22
1968 24
1969 26
1970 16
1971 24
1972 42
1973 27
1974 43
1975 44
1976 37
1977 39
1978 39
1979 45
1980 39
1981 32
1982 30
1983 38
1984 36
1985 20
1986 33
1987 28
1988 31
1989 33
1990 24
1991 22
1992 25
1993 22
1994 16
1995 23
1996 13
1997 19
1998 13
1999 15
2000 27
2001 20
2002 20
2003 13
2004 23
2005 19
2006 20
2007 29
2008 26
2009 19
2010 25
2011 22
2012 28
2013 31
2014 25
2015 30
2016 25
2017 17
2018 14
2019 24
2020 22
2021 21
2022 17
2023 24
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

1,892 results

Results by year

Filters applied: . Clear all
Page 1
Malignant Hypertension: Current Perspectives and Challenges.
Boulestreau R, van den Born BH, Lip GYH, Gupta A. Boulestreau R, et al. J Am Heart Assoc. 2022 Apr 5;11(7):e023397. doi: 10.1161/JAHA.121.023397. Epub 2022 Mar 15. J Am Heart Assoc. 2022. PMID: 35289189 Free PMC article. Review.
Malignant hypertension.
Kincaid-Smith P. Kincaid-Smith P. J Hypertens. 1991 Oct;9(10):893-9. J Hypertens. 1991. PMID: 1658131 No abstract available.
Malignant hypertension: does this still exist?
Domek M, Gumprecht J, Lip GYH, Shantsila A. Domek M, et al. J Hum Hypertens. 2020 Jan;34(1):1-4. doi: 10.1038/s41371-019-0267-y. Epub 2019 Oct 21. J Hum Hypertens. 2020. PMID: 31636349 No abstract available.
Pharmacological management of malignant hypertension.
Lewek J, Bielecka-Dąbrowa A, Maciejewski M, Banach M. Lewek J, et al. Expert Opin Pharmacother. 2020 Jul;21(10):1189-1192. doi: 10.1080/14656566.2020.1732923. Epub 2020 Feb 26. Expert Opin Pharmacother. 2020. PMID: 32100590 Review.
Malignant hypertension causing severe chorioretinopathy.
Basilious A, McInnis RL, Juncal VR. Basilious A, et al. Can J Ophthalmol. 2023 Aug;58(4):e160. doi: 10.1016/j.jcjo.2022.11.009. Epub 2022 Dec 5. Can J Ophthalmol. 2023. PMID: 36481184 No abstract available.
The pharmacological management of malignant hypertension.
Gosse P, Boulestreau R, Brockers C, Puel C, Rubin S, Cremer A. Gosse P, et al. J Hypertens. 2020 Nov;38(11):2325-2330. doi: 10.1097/HJH.0000000000002547. J Hypertens. 2020. PMID: 32649635 Review.
1,892 results